In this issue...
The work of the WBBA is dramatically extended by a network of business and scientific experts who are working to build a leading life sciences community globally. Committee descriptions are available online. Please e-mail the assigned staff member if you are interested in volunteering on one of our important committees:
If you are a student in the Life Sciences or are a member of the WBBA and would like to volunteer for our Annual Meeting & Governor’s Summit on Friday, November 18, we would like to hear from you! In exchange for volunteering you get a free pass to the event and exposure to many Life Sciences leaders. You will also enjoy hearing from some of our most innovative leaders today as well as the Governor, Christine Gregoire. Please submit your information for review.
Thank you again for your interest in volunteering… we couldn’t do it without you!
Did you know...
you can update your subscriptions for email communications from WBBA?
1. Go to www.washbio.org and select Member Center, Edit Profile from the top navigation panel
While you're there, you can update your profile fields too!
VIP Forum- New Format
The WBBA’s Venture Investment and Partnering (VIP) Forum has a new twist! During VIP Forums, investors and strategic partners travel to Seattle for a customized, day-long schedule of one-on-one meetings with the region’s most promising life science companies, entrepreneurs, researchers and emerging companies, who are pre-selected during an application process. In tandem with the one-on-one meetings, we are now offering the chance for the community to hear directly from the visiting VIPs during a seminar and networking session. All are welcome at these informational sessions; there is no cost to attend.
The next VIP Forum is scheduled with Bayer Healthcare on October 5th. Applications for one-on-one meetings are closed, however we encourage all interested individuals and organizations to register for the breakfast seminar "Partnering with Bayer HealthCare".
Event Review – Driving Healthcare Innovation Through Venturing
WBBA’s Venture Investment and Partnering (VIP) Forum proudly presented Driving Healthcare Innovation Through Venturing: Introducing Merck Global Health Innovation on Tuesday, August 23. Merck Global Health Innovation (GHI) seeks to identify new business models and adjacency opportunities in the healthcare marketplace that may not fit immediately into Merck's traditional pharmaceutical and vaccine business units. This includes service solutions, products and technology. If you missed the presentation, you can view the slides online. Thank you to our host Seattle BioMed for the generous use of their meeting space, and to Merck GHI for sponsoring the seminar and networking event.
WINGS, The Washington Medical Technology Angel Network is a joint initiative of WBBA and the medical technology community. WINGS’s mission is to close the gap in early stage funding to accelerate the translation of medical technology innovation from the lab bench to patients. WINGS held its third Investor Meeting of 2011 with company presentations from Aseptica, Sinuwave and Wyngate Medical, as well as company updates from Mirador and Spiral Genetics.
Aseptica has developed an antimicrobial catheter-lock to prevent central venous catheter infections. Sinuwave is a spin-out of Ondine Biomedical and is adapting a proven disposable drug-device combination technology for the treatment of chronic sinusitis. Wyngate Medical is developing WynVent- the first ever oxygen generating ventilator.
The WINGS network is looking forward to its last quarterly investor meeting of 2011 on October 18 (applications closed) and its first meeting of 2012 on February 15. Emerging medical technology companies are encouraged to apply to present. To be considered for the next round of screening, applications are due on January 10, 2012 for the February investor meeting. For more information on how to apply to present, to become a WINGS investor or to sponsor WINGS visit www.medtechwings.com or email email@example.com.
WINGS was recently profiled in the Puget Sound Business Journal. With 8 of the first 18 presenting companies receiving some investment through WINGS and/or other sources, the WINGS Angel Network has established itself as a viable source of capital and business expertise for local, emerging medical device companies.
WINGS is sponsored by: WBBA, Perkins Coie, WRF Capital, University of Washington Center for Commercialization, Broadmark Capital, Silicon Valley Bank, SonoSite, Stratos, Vertex, Philips and Physio-Control/Medtronic.
Are you forming a company, writing a business plan, or looking to raise capital? Or are you a WBBA member/consultant or with years of experience commercializing medical products, writing successful SBIR grants or executing regulatory strategies? Check out lifesciencestartup.com, the WBBA-hosted wiki website full of resources and information for early-stage life science entrepreneurs AND for experts, mentors and service providers who have advice and expertise to contribute to the life sciences community in Washington state. To suggest a new page or add content, just visit the site and create an account.
Pro Bono Consulting
Chris Porter and Christiana DelloRusso are available to offer guidance and mentoring to WBBA member organizations. You can schedule a meeting with them by emailing firstname.lastname@example.org. The Commercialization Team’s focus for 2011 remains on access to capital and formalized investor relations both inside and outside of the state.